Radić, M.; Vlašić, I.; Jazvinšćak Jembrek, M.; Horvat, A.; Tadijan, A.; Sabol, M.; Dužević, M.; Herak Bosnar, M.; Slade, N.
Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance. Int. J. Mol. Sci. 2022, 23, 9910.
https://doi.org/10.3390/ijms23179910
AMA Style
Radić M, Vlašić I, Jazvinšćak Jembrek M, Horvat A, Tadijan A, Sabol M, Dužević M, Herak Bosnar M, Slade N.
Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance. International Journal of Molecular Sciences. 2022; 23(17):9910.
https://doi.org/10.3390/ijms23179910
Chicago/Turabian Style
Radić, Martina, Ignacija Vlašić, Maja Jazvinšćak Jembrek, Anđela Horvat, Ana Tadijan, Maja Sabol, Marko Dužević, Maja Herak Bosnar, and Neda Slade.
2022. "Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance" International Journal of Molecular Sciences 23, no. 17: 9910.
https://doi.org/10.3390/ijms23179910
APA Style
Radić, M., Vlašić, I., Jazvinšćak Jembrek, M., Horvat, A., Tadijan, A., Sabol, M., Dužević, M., Herak Bosnar, M., & Slade, N.
(2022). Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance. International Journal of Molecular Sciences, 23(17), 9910.
https://doi.org/10.3390/ijms23179910
